IL-10 Muteins Patent - University of Dundee et al
Summary
The EPO granted patent EP4118104A1 to University of Dundee and co-applicants INSERM, Université de Lille, and CHRU Lille covering IL-10 muteins (modified cytokine variants), with protection extending across 31 designated European states. The patent covers modified interleukin-10 proteins with enhanced anti-inflammatory and immunomodulatory properties for potential therapeutic applications.
What changed
The EPO published patent application EP4118104A1 for IL-10 muteins (modified interleukin-10 cytokines), granted to University of Dundee and co-applicants INSERM, Université de Lille, and CHRU de Lille. The designated states include all 27 EU member states plus Switzerland, Norway, Iceland, Turkey, and other European states.
Academic research institutions and biotech or pharmaceutical companies developing interleukin-10 related therapeutics, anti-inflammatory drugs, or immunomodulatory treatments should assess potential patent infringement risks and licensing requirements. Freedom-to-operate analyses for any products in these therapeutic areas will need to account for this granted European patent.
What to do next
- Monitor for updates on patent enforcement activities
- Assess freedom-to-operate for related therapeutic development
- Evaluate licensing opportunities if developing competing IL-10 variants
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
IL-10 MUTEINS
Publication EP4118104A1 Kind: A1 Apr 01, 2026
Applicants
University of Dundee, Institut National de la Santé et de la
Recherche Médicale (INSERM), Université de Lille, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE
Inventors
GORBY, Claire, GONZALEZ, Ignacio Moraga, MITRA, Suman
IPC Classifications
C07K 14/52 20060101AFI20210917BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.